compound · derived
Actinium Ac 225-DOTA-Daratumumab
2 trials · 0 approvals
| Trials | 2 |
|---|---|
| Approvals | 0 |
| Phases | Phase 1 |
Provenance
- Source: Derived from ClinicalTrials.gov and openFDA
- Fetched at: 2026-10-30T14:45:47.693Z
- Licence class: internal-only
- Verdict: derived
- Entity id: actinium ac 225-dota-daratumumab
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Actinium Ac 225-DOTA-Daratumumab · trial
- Actinium Ac 225-DOTA-Daratumumab · trial